A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis

BMC Systems Biology

Volumn 3, Issue , 2009, Pages 92-

  Fang, Xin ^a   Wallqvist, Anders ^a   Reifman, Jaques ^a  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; 3-NITROPROPIONIC ACID; BACTERIAL PROTEIN; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE; SUCCINATE DEHYDROGENASE;

ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

BACTERIAL PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; NITRO COMPOUNDS; PROPIONIC ACIDS; SIGNAL TRANSDUCTION; SUCCINATE DEHYDROGENASE; SYSTEMS BIOLOGY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 70449513046     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-3-92     Document Type: Article

References (67)

1. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001, 2:343-372. 10.1146/annurev.genom.2.1.343, 11701654.
2. Kell DB. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today 2006, 11:1085-1092. 10.1016/j.drudis.2006.10.004, 17129827.
3. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J. Cancer: a Systems Biology disease. Biosystems 2006, 83:81-90. 10.1016/j.biosystems.2005.05.014, 16426740.
4. Cho CR, Labow M, Reinhardt M, van Oostrum J, Peitsch MC. The application of systems biology to drug discovery. Curr Opin Chem Biol 2006, 10:294-302. 10.1016/j.cbpa.2006.06.025, 16822703.
5. Joyce AR, Palsson BO. Toward whole cell modeling and simulation: comprehensive functional genomics through the constraint-based approach. Prog Drug Res 2007, 64:267-309. 17195479 .
6. Francke C, Siezen RJ, Teusink B. Reconstructing the metabolic network of a bacterium from its genome. Trends Microbiol 2005, 13:550-558. 10.1016/j.tim.2005.09.001, 16169729.
7. Breitling R, Vitkup D, Barrett MP. New surveyor tools for charting microbial metabolic maps. Nat Rev Microbiol 2008, 6:156-161. 10.1038/nrmicro1797, 18026122.
8. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-484. 10.1093/nar/gkm882, 2238879, 18077471.
9. Suthers PF, Dasika MS, Kumar VS, Denisov G, Glass JI, Maranas CD. A genome-scale metabolic reconstruction of Mycoplasma genitalium, iPS189. PLoS Comput Biol 2009, 5:e1000285. 10.1371/journal.pcbi.1000285, 2633051, 19214212.
10. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, Karp PD, Broadbelt LJ, Hatzimanikatis V, Palsson BO. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 2007, 3:121. 10.1038/msb4100155, 1911197, 17593909.
11. Thiele I, Vo TD, Price ND, Palsson BO. Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J Bacteriol 2005, 187:5818-5830. 10.1128/JB.187.16.5818-5830.2005, 1196094, 16077130.
12. Oh YK, Palsson BO, Park SM, Schilling CH, Mahadevan R. Genome-scale reconstruction of metabolic network in Bacillus subtilis based on high-throughput phenotyping and gene essentiality data. J Biol Chem 2007, 282:28791-28799. 10.1074/jbc.M703759200, 17573341.
13. Kjeldsen KR, Nielsen J. In silico genome-scale reconstruction and validation of the Corynebacterium glutamicum metabolic network. Biotechnol Bioeng 2009, 102:583-597. 10.1002/bit.22067, 18985611.
14. Duarte NC, Herrgard MJ, Palsson BO. Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res 2004, 14:1298-1309. 10.1101/gr.2250904, 442145, 15197165.
15. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 2007, 104:1777-1782. 10.1073/pnas.0610772104, 1794290, 17267599.
16. Klipp E. Systems biology in practice: concepts, implementation and application 2005, Weinheim: Wiley-VCH.
17. Palsson B. Systems biology: properties of reconstructed networks 2006, New York: Cambridge University Press.
18. Jamshidi N, Edwards JS, Fahland T, Church GM, Palsson BO. Dynamic simulation of the human red blood cell metabolic network. Bioinformatics 2001, 17:286-287. 10.1093/bioinformatics/17.3.286, 11294796.
19. Young JD, Henne KL, Morgan JA, Konopka AE, Ramkrishna D. Integrating cybernetic modeling with pathway analysis provides a dynamic, systems-level description of metabolic control. Biotechnol Bioeng 2008, 100:542-559. 10.1002/bit.21780, 18438875.
20. Jamshidi N, Wiback SJ, Palsson BB. In silico model-driven assessment of the effects of single nucleotide polymorphisms (SNPs) on human red blood cell metabolism. Genome Res 2002, 12:1687-1692. 10.1101/gr.329302, 187553, 12421755.
21. Singh VK, Ghosh I. Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets. Theor Biol Med Model 2006, 3:27. 10.1186/1742-4682-3-27, 1563452, 16887020.
22. Edwards JS, Palsson BO. Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinformatics 2000, 1:1. 10.1186/1471-2105-1-1, 29061, 11001586.
23. Famili I, Forster J, Nielsen J, Palsson BO. Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc Natl Acad Sci USA 2003, 100:13134-13139. 10.1073/pnas.2235812100, 263729, 14578455.
24. Barrett CL, Kim TY, Kim HU, Palsson BO, Lee SY. Systems biology as a foundation for genome-scale synthetic biology. Curr Opin Biotechnol 2006, 17:488-492. 10.1016/j.copbio.2006.08.001, 16934450.
25. Hjersted JL, Henson MA, Mahadevan R. Genome-scale analysis of Saccharomyces cerevisiae metabolism and ethanol production in fed-batch culture. Biotechnol Bioeng 2007, 97:1190-1204. 10.1002/bit.21332, 17243146.
26. Edwards JS, Palsson BO. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. Proc Natl Acad Sci USA 2000, 97:5528-5533. 10.1073/pnas.97.10.5528, 25862, 10805808.
27. Trawick JD, Schilling CH. Use of constraint-based modeling for the prediction and validation of antimicrobial targets. Biochem Pharmacol 2006, 71:1026-1035. 10.1016/j.bcp.2005.10.049, 16329998.
28. Volpe E, Cappelli G, Grassi M, Martino A, Serafino A, Colizzi V, Sanarico N, Mariani F. Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology 2006, 118:449-460. 1782319, 16895554.
29. Wang JP, Rought SE, Corbeil J, Guiney DG. Gene expression profiling detects patterns of human macrophage responses following Mycobacterium tuberculosis infection. FEMS Immunol Med Microbiol 2003, 39:163-172. 10.1016/S0928-8244(03)00223-2, 14625100.
30. Mahadevan R, Edwards JS, Doyle FJ. Dynamic flux balance analysis of diauxic growth in Escherichia coli. Biophys J 2002, 83:1331-1340. 10.1016/S0006-3495(02)73903-9, 1302231, 12202358.
31. World Health Organization WHO Report 2008: Global tuberculosis control - surveillance, planning, financing. 2008, World Health Organization. Geneva.
32. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 2008, 3:399-407. 10.1016/j.chom.2008.05.006, 18541216.
33. Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998, 66:1277-1281. 108049, 9529042.
34. Vergne I, Chua J, Singh SB, Deretic V. Cell biology of mycobacterium tuberculosis phagosome. Annu Rev Cell Dev Biol 2004, 20:367-394. 10.1146/annurev.cellbio.20.010403.114015, 15473845.
35. Sundaramurthy V, Pieters J. Interactions of pathogenic mycobacteria with host macrophages. Microbes Infect 2007, 9:1671-1679. 10.1016/j.micinf.2007.09.007, 18023233.
36. Munoz-Elias EJ, Timm J, Botha T, Chan WT, Gomez JE, McKinney JD. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect Immun 2005, 73:546-551. 10.1128/IAI.73.1.546-551.2005, 538940, 15618194.
37. Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol 2004, 52:1291-1302. 10.1111/j.1365-2958.2004.04078.x, 15165233.
38. Munoz-Elias EJ, McKinney JD. Carbon metabolism of intracellular bacteria. Cell Microbiol 2006, 8:10-22. 10.1111/j.1462-5822.2005.00648.x, 16367862.
39. Young DB, Perkins MD, Duncan K, Barry CE. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008, 118:1255-1265. 10.1172/JCI34614, 2276805, 18382738.
40. Anishetty S, Pulimi M, Pennathur G. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem 2005, 29:368-378. 10.1016/j.compbiolchem.2005.07.001, 16213791.
41. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544. 10.1038/31159, 9634230.
42. Jamshidi N, Palsson BO. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol 2007, 1:26. 10.1186/1752-0509-1-26, 1925256, 17555602.
43. Beste DJ, Hooper T, Stewart G, Bonde B, Avignone-Rossa C, Bushell ME, Wheeler P, Klamt S, Kierzek AM, McFadden J. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol 2007, 8:R89. 10.1186/gb-2007-8-5-r89, 1929162, 17521419.
44. Gould TA, Langemheen H, Munoz-Elias EJ, McKinney JD, Sacchettini JC. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. Mol Microbiol 2006, 61:940-947. 10.1111/j.1365-2958.2006.05297.x, 16879647.
45. Munoz-Elias EJ, Upton AM, Cherian J, McKinney JD. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol 2006, 60:1109-1122. 10.1111/j.1365-2958.2006.05155.x, 16689789.
46. Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 2005, 11:638-644. 10.1038/nm1252, 1464426, 15895072.
47. Gobin J, Horwitz MA. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. J Exp Med 1996, 183:1527-1532. 10.1084/jem.183.4.1527, 2192514, 8666910.
48. Fischbach MA, Lin H, Liu DR, Walsh CT. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol 2006, 2:132-138. 10.1038/nchembio771, 16485005.
49. De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y, Barry CE. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci USA 2000, 97:1252-1257. 10.1073/pnas.97.3.1252, 15586, 10655517.
50. Quadri LE. Assembly of aryl-capped siderophores by modular peptide synthetases and polyketide synthases. Mol Microbiol 2000, 37:1-12. 10.1046/j.1365-2958.2000.01941.x, 10931301.
51. Chou CJ, Wisedchaisri G, Monfeli RR, Oram DM, Holmes RK, Hol WG, Beeson C. Functional studies of the Mycobacterium tuberculosis iron-dependent regulator. J Biol Chem 2004, 279:53554-53561. 10.1074/jbc.M407385200, 15456786.
52. Crosa JH, Walsh CT. Genetics and assembly line enzymology of siderophore biosynthesis in bacteria. Microbiol Mol Biol Rev 2002, 66:223-249. 10.1128/MMBR.66.2.223-249.2002, 120789, 12040125.
53. Ferreras JA, Ryu JS, Di Lello F, Tan DS, Quadri LE. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. Nat Chem Biol 2005, 1:29-32. 10.1038/nchembio706, 16407990.
54. Segre D, Vitkup D, Church GM. Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci USA 2002, 99:15112-15117. 10.1073/pnas.232349399, 137552, 12415116.
55. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2007, 2:727-738. 10.1038/nprot.2007.99, 17406635.
56. Edwards JS, Palsson BO. How will bioinformatics influence metabolic engineering?. Biotechnol Bioeng 1998, 58:162-169. 10.1002/(SICI)1097-0290(19980420)58:2/3<162::AID-BIT8>3.0.CO;2-J, 10191386.
57. Raman K, Chandra N. Flux balance analysis of biological systems: applications and challenges. Brief Bioinform 2009, 10:435-449. 10.1093/bib/bbp011, 19287049.
58. Grafahrend-Belau E, Schreiber F, Koschutzki D, Junker BH. Flux balance analysis of barley seeds: a computational approach to study systemic properties of central metabolism. Plant Physiol 2009, 149:585-598. 10.1104/pp.108.129635, 18987214.
59. Sahle S, Mendes P, Hoops S, Kummer U. A new strategy for assessing sensitivities in biochemical models. Philos Transact A Math Phys Eng Sci 2008, 366:3619-3631. 10.1098/rsta.2008.0108, 18632455.
60. van Riel NA. Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments. Brief Bioinform 2006, 7:364-374. 10.1093/bib/bbl040, 17107967.
61. Schomburg I, Chang A, Schomburg D. BRENDA, enzyme data and metabolic information. Nucleic Acids Res 2002, 30:47-49. 10.1093/nar/30.1.47, 99121, 11752250.
62. Hunter GJ, Hamberg LM, Alpert NM, Choi NC, Fischman AJ. Simplified measurement of deoxyglucose utilization rate. J Nucl Med 1996, 37:950-955.
63. Al Zaid Siddiquee K, Arauzo-Bravo MJ, Shimizu K. Metabolic flux analysis of pykF gene knockout Escherichia coli based on 13C-labeling experiments together with measurements of enzyme activities and intracellular metabolite concentrations. Appl Microbiol Biotechnol 2004, 63:407-417. 10.1007/s00253-003-1357-9, 12802531.
64. Wensink H, Benito-Lopez F, Hermes DC, Verboom W, Gardeniers HJ, Reinhoudt DN, Berg A. Measuring reaction kinetics in a lab-on-a-chip by microcoil NMR. Lab Chip 2005, 5:280-284. 10.1039/b414832k, 15726204.
65. Edwards JS, Ibarra RU, Palsson BO. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol 2001, 19:125-130. 10.1038/84379, 11175725.
66. Nathan C. Role of iNOS in human host defense. Science 2006, 312:1874-1875. author reply 1874-1875., 10.1126/science.312.5782.1874b, 16809512.
67. Becker SA, Palsson BO. Context-specific metabolic networks are consistent with experiments. PLoS Comput Biol 2008, 4:e1000082. 10.1371/journal.pcbi.1000082, 2366062, 18483554.